Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Clin Endocrinol (Oxf) ; 65(5): 648-54, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17054468

ABSTRACT

OBJECTIVE: The pathogenesis of human pituitary adenomas remains unclear, but we report a case of FSH-secreting pituitary adenoma whose monohormonal phenotype suggests it was of fetal origin. PATIENTS: A 28-year-old woman presented with abdominal discomfort and irregular menses, enlarged multicystic ovaries and elevated serum oestradiol, with sustained high-normal FSH and low LH levels. MEASUREMENTS: Endocrine studies were performed before and after curative surgery, with assessment of tumour hormone secretion in vitro, and immunostaining of tumour tissue for a series of gonadotrope proteins. RESULTS: Immunocytochemistry showed that tumour cells were monohormonal for FSH. Normal components of gonadotrope signalling pathways were expressed, including oestrogen receptor-alpha, activin receptors, secretogranin-II and chromogranin-A. beta-glycan, the putative inhibin coreceptor, was absent. Tumour culture in vitro confirmed secretion of FSH with minimal LH, that was unsuppressed by oestradiol or inhibin-A. Human fetal pituitary tissue contained FSH-only cells at 18 weeks gestation, whereas normal adult pituitary tissue contained only bihormonal gonadotropes. CONCLUSIONS: We propose that this pituitary adenoma represents an indolent tumour of monohormonal fetal gonadotrope cells that originated early in gestation. Pituitary tumours may therefore arise from abnormal persistence of fetal cell types, with extremely slow growth over many years until reaching a size threshold to generate an endocrine syndrome. Understanding fetal pituitary architecture and function may be more informative for new insights into pituitary tumour pathogenesis than classical theories of cancer biology that invoke unrestrained cell proliferation.


Subject(s)
Adenoma/embryology , Gonadotrophs/metabolism , Pituitary Neoplasms/embryology , Adenoma/complications , Adenoma/metabolism , Adult , Estradiol/blood , Female , Follicle Stimulating Hormone/analysis , Follicle Stimulating Hormone/blood , Follicle Stimulating Hormone/metabolism , Humans , Immunohistochemistry/methods , Immunoradiometric Assay/methods , Luteinizing Hormone/blood , Pituitary Gland, Anterior/embryology , Pituitary Gland, Anterior/metabolism , Pituitary Neoplasms/complications , Pituitary Neoplasms/metabolism , Polycystic Ovary Syndrome/blood , Polycystic Ovary Syndrome/embryology , Polycystic Ovary Syndrome/etiology , Tissue Culture Techniques
2.
J Comp Pathol ; 132(4): 329-39, 2005 May.
Article in English | MEDLINE | ID: mdl-15893991

ABSTRACT

Cyclin D3 is a tightly regulated cell cycle protein and member of the cyclin D family-a group of proteins that facilitates the progression of a cell through G(1) and into the S phase of the cell cycle. All cells use at least one of the cyclin D proteins for cell cycle regulation. In this study, feline tissues (normal fetal and adult, and neoplastic) were examined immunohistochemically for expression and topographical distribution of cyclin D3. Its distribution was similar to that in human tissues in health and neoplasia, and suggested a dual role of cyclin D3 in cell proliferation and differentiation. Immature lymphoid tissue and proliferating epithelial cells in health and neoplasia were immunoreactive for cyclin D3, whereas expression of the protein in other immunoreactive tissues reflected differentiated cell types. Immunoreactivity for cyclin D3 was particularly striking in germinal centre cells of normal lymph nodes and B-cell lymphomas, and in normal suprabasal epithelial cells of the skin and mucous membranes of the oropharynx and in squamous cell carcinomas at these sites.


Subject(s)
Cat Diseases/metabolism , Cyclins/metabolism , Fetus/metabolism , Lymphoid Tissue/metabolism , Neoplasms/veterinary , Animals , Biomarkers, Tumor/metabolism , Cat Diseases/pathology , Cats , Cyclin D3 , Female , Immunohistochemistry/methods , Immunohistochemistry/veterinary , Lymphoid Tissue/cytology , Neoplasms/metabolism , Neoplasms/pathology , Pregnancy
3.
Vet Pathol ; 42(1): 35-41, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15657270

ABSTRACT

Progressive respiratory failure and pulmonary fibrosis in West Highland White Terriers (WHWT) is an apparently genetic disorder of unknown pathogenesis. This study characterizes the light microscopic, ultrastructural, and immunohistochemical features of affected WHWT in comparison with lesions in usual interstitial pneumonia (UIP) of humans. Lesions in WHWT were confined to the expansion of the interstitial space of alveolar septa by extracellular matrix (ECM) determined to be mixtures of type-I and -III collagens. Features of UIP such as intra-alveolar fibroblastic foci, subpleural distribution, and honeycombing were not observed in six WHWT. Comparison with normal dogs showed no apparent increase in septal myofibroblasts. Ultrastructually, the ECM in alveolar septa consisted of large aggregates of periodic collagen filaments underlying alveolar capillaries that were surrounded by thick bands of amorphous to fine fibrillar matrix. This study suggests that chronic pulmonary disease of WHWT is a result of aberrant collagen regulation.


Subject(s)
Dog Diseases/pathology , Lung Diseases, Interstitial/veterinary , Animals , Collagen Type I/metabolism , Collagen Type III/metabolism , Dog Diseases/metabolism , Dogs , Extracellular Matrix/metabolism , Extracellular Matrix/pathology , Extracellular Matrix/ultrastructure , Female , Humans , Immunohistochemistry/veterinary , Lung Diseases, Interstitial/metabolism , Lung Diseases, Interstitial/pathology , Male , Microscopy, Electron/veterinary , Retrospective Studies
5.
Cell Mol Biol (Noisy-le-grand) ; 49(5): 799-807, 2003 Jul.
Article in English | MEDLINE | ID: mdl-14528917

ABSTRACT

Humans deficient in the cerebroside-sulfate activator protein (CSAct or Saposin B) are unable to catabolize sulfatide and other glycosphingolipids leading to their accumulation and neurodegenerative disease. Clinically this usually manifests as a form of metachromatic leukodystrophy (MLD). CSAct is a small water-soluble glycoprotein that apparently functions in the lysosome to solubilize sulfatide and other lipids enabling their interaction with soluble lysosomal hydrolases. CSAct activity can be measured in vitro by assay of its ability to activate sulfatide-sulfate hydrolysis by arylsulfatase A or ex vivo by its ability to functionally complement CSAct deficient fibroblast cell lines derived from MLD patients. A recombinant form of CSAct has been expressed in E. coli and processed in vitro to a form covalently indistinguishable from deglycosylated human CSAct isolated from human urine. Size-exclusion chromatography in combination with multi-angle laser-light scattering (SEC-MALLS) measurements demonstrate that both native and recombinant forms of the molecule behave as a dimer in the pH range 7.0-4.5. The CSAct activity assay showed that both recombinant and deglycosylated human urine CSAct efficiently activated sulfatide sulfate hydrolysis and provided functional complementation of CSAct-deficient cells. However, a D21N mutant form of recombinant CSAct could not functionally complement these cells despite full activity in the in vitro assay. It is concluded that while glycosylation is unnecessary for in vitro and ex vivo activity of CSAct, modification of the native N21 is necessary to prevent loss of ex vivo activity, possibly via protection from degradation.


Subject(s)
Glycoproteins/chemistry , Recombinant Proteins/chemistry , Aminopeptidases/chemistry , Aminopeptidases/metabolism , Animals , Cerebroside-Sulfatase/metabolism , Chromatography, High Pressure Liquid , Cloning, Molecular , Cyanogen Bromide/chemistry , Disulfides/chemistry , Fibroblasts/enzymology , Fibroblasts/metabolism , Gene Expression , Glycoproteins/biosynthesis , Glycoproteins/deficiency , Humans , Kinetics , Molecular Weight , Protein Structure, Quaternary , Recombinant Proteins/biosynthesis , Scattering, Radiation , Spectrometry, Mass, Electrospray Ionization , Sphingolipid Activator Proteins , Sulfoglycosphingolipids/metabolism , Swine
6.
J Endocrinol ; 178(1): 61-9, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12844337

ABSTRACT

Although analysis of luciferase activity using luminescence imaging has provided new insights into the dynamic regulation of gene expression in living tIssues, studies in vitro have relied on stably transfected clonal cell lines, limiting the choice of cell type and species, or DNA microinjection, which is arduous and highly selective. We report here the first use of a recombinant adenovirus in which the firefly luciferase reporter gene was regulated by the prolactin gene promoter, to study temporal dynamics of promoter activity. This vector was used to infect the pituitary GH3 cell line, and also primary cultures of Syrian hamster pituitary cells. We show that adenovirally transduced cells retained normal regulation of the promoter-reporter transgene by appropriate signals. Furthermore, microscopic imaging studies indicated that both clonal and primary pituitary cells were transduced efficiently, giving readily detectable luminescence signals in real-time over long periods. Finally, analysis of single-cell expression patterns indicated that prolactin promoter activity was highly dynamic with pulses in gene expression, revealing that the transcriptional instability seen in clonal cells is a feature of normal pituitary cells. Adenoviral vectors offer a valuable tool for studies of gene regulation where conventional transgenesis and clonal cell lines are not available.


Subject(s)
Pituitary Gland, Anterior/metabolism , Prolactin/genetics , Promoter Regions, Genetic , Transcription, Genetic , Adenoviridae/genetics , Adolescent , Analysis of Variance , Cells, Cultured , Clone Cells , Colforsin/pharmacology , Gene Expression , Genetic Vectors/administration & dosage , Humans , Luciferases/genetics , Luminescent Measurements , Microscopy, Electron , Prolactin/metabolism , Transgenes
7.
Mol Endocrinol ; 17(2): 193-202, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12554747

ABSTRACT

Real-time imaging of the GH gene promoter linked to luciferase in living pituitary cells has revealed surprising heterogeneity and variety of dynamic patterns of gene expression. Cells treated with either forskolin or thyroid hormone generated a consistent and characteristic temporal response from cell populations, but detailed analysis of individual cells revealed different patterns. Approximately 25-26% of cells displayed no response, 25-33% of cells exhibited a sustained progressive rise in luciferase activity, and 41-50% showed a transient phasic, or oscillatory response, after given stimuli. In cells treated consecutively with the two stimuli, the population response to the second stimulus was augmented. Single-cell analysis revealed that this was partly due to an increased number of cells responding, but also that the prevalence of response patterns changed: cells that responded to an initial stimulus were more likely to respond subsequently in a progressive sustained manner. In conclusion, these studies have indicated that GH promoter activity in individual living pituitary cells is unstable and possibly stochastic, with dynamic variations from hour to hour. The prevalence of different temporal patterns of response to hormonal stimulation among a population of cells is altered by the endocrine history of those cells.


Subject(s)
Human Growth Hormone/genetics , Human Growth Hormone/metabolism , Pituitary Gland/cytology , Pituitary Gland/physiology , Transcription, Genetic , Animals , Cells, Cultured , Colforsin/pharmacology , Cyclic AMP/pharmacology , Human Growth Hormone/drug effects , Humans , Luciferases/drug effects , Luciferases/genetics , Luciferases/metabolism , Pituitary Gland/drug effects , Rats , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Time Factors , Triiodothyronine/pharmacology
8.
Endocrinology ; 142(7): 3255-60, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11416049

ABSTRACT

PRL gene expression in the anterior pituitary gland responds rapidly to different hormonal signals. We have investigated the long-term timing of transcriptional activation from the PRL, GH, and cytomegalovirus promoters in response to different stimulus duration, using real-time imaging of luciferase expression in living stably transfected GH3 cells. Long-term stimulation of serum-starved cells with 50% serum induced a homogeneous rise in PRL promoter activity, with subsequent heterogeneous fluctuations in luciferase activity in individual cells. When cells were subjected to a 2-h pulse of 50% serum, followed by serum-free medium, there were long-term (approximately 50 h) synchronized, homogeneous oscillations in PRL promoter activity. This response was PRL-specific, because in GH3 cells expressing luciferase from the GH or cytomegalovirus promoters, a serum pulse elicited no oscillations in luciferase expression after an initial transient response to serum. The PRL promoter may therefore be a template for an unstable transcription complex subject to stochastic regulation, allowing an oscillatory transcriptional response to physiological signals. This suggests that precise timing and coordination of cell responses to different signal-duration may represent a novel mechanism for coordinating long-term dynamic changes in transcription in cell populations.


Subject(s)
Pituitary Gland/physiology , Prolactin/genetics , Promoter Regions, Genetic/physiology , Blood Physiological Phenomena , Cell Cycle/physiology , Cell Line , Humans , Luminescent Measurements , Oscillometry , Pituitary Gland/cytology , Time Factors
9.
Biochemistry ; 40(13): 3774-9, 2001 Apr 03.
Article in English | MEDLINE | ID: mdl-11300757

ABSTRACT

An accurate, rapid, and versatile method for the analysis of enzyme kinetics using electrospray ionization mass spectrometry (ESI-MS) has been developed and demonstrated using fucosyltransferase V. Reactions performed in primary or secondary amine-containing buffers were diluted in an ESI solvent and directly analyzed without purification of the reaction products. Decreased mass resolution was used to maximize instrument sensitivity, and multiple reaction monitoring (MRM), in the tandem mass spectrometric mode, was used to enhance selectivity of detection. The approach allowed simultaneous monitoring of multiple processes, including substrate consumption, product formation, and the intensity of an internal standard. MRM gave an apparent K(m) for GDP-L-fucose (GDP-Fuc) of 50.4 +/- 5.5 microM and a k(cat) of 1.46 +/- 0.044 s(-1). Under the same conditions, the conventional radioactivity-based assay using GDP-[U-(14)C]Fuc as substrate gave virtually identical results: K(m) = 54.3 +/- 4.6 microM and k(cat) = 1.49 +/- 0.039 s(-1). The close correlation of the data showed that ESI-MS coupled to MRM is a valid approach for the analysis of enzyme kinetics. Consequently, this method represents a valuable alternative to existing analytic methods because of the option of simultaneously monitoring multiple species, the high degree of specificity, and rapid analysis times and because it does not rely on the availability of radioactive or chromogenic substrates.


Subject(s)
Fucosyltransferases/chemistry , Amino Sugars/chemistry , Amino Sugars/metabolism , Binding Sites , Buffers , Carbohydrate Sequence , Electron Transport , Fucose/analogs & derivatives , Fucose/chemistry , Fucose/metabolism , Fucosyltransferases/metabolism , Guanosine Diphosphate/analogs & derivatives , Guanosine Diphosphate/chemistry , Guanosine Diphosphate/metabolism , Humans , Hydrogen-Ion Concentration , Ions/chemistry , Kinetics , Lewis X Antigen/analogs & derivatives , Molecular Sequence Data , Nucleotides/chemistry , Nucleotides/metabolism , Spectrometry, Mass, Electrospray Ionization/methods , Trisaccharides/chemistry , Trisaccharides/metabolism
10.
Anal Chem ; 73(24): 6024-9, 2001 Dec 15.
Article in English | MEDLINE | ID: mdl-11791575

ABSTRACT

Electrospray ionization mass spectrometry coupled to multiple reaction monitoring (ESI-MS/MRM) has been applied for the first time to analyze enzyme inhibitor kinetics. Specifically, a known competitive inhibitor, guanosine 5'-monophosphate (GMP), and a synthetic, transition-state analogue inhibitor, guanosine 5'-[1D-(1,3,4/2)-5-methyl-5-cyclohexene-1,2,3,4-tetrol 1-diphosphate] (1) have been characterized against recombinant fucosyltransferase (Fuc-T) V using ESI-MS/MRM. Dixon analysis with GMP yielded a signature plot for competitive inhibition. Nonlinear regression analysis gave a Ki of 211.8+/-24.7 microM. The conventional analysis using GDP-[U-14C]-Fuc yielded a similar Ki value of 235.6+/-59.4 microM, confirming the validity of the MS-based method. The synthetic inhibitor 1 showed potent competitive inhibition with a Ki of 25.6+/-2.8 microM. Although 1 possesses a chemically reactive allyl phosphate group, ESI-MS/MRM showed that there was no reduction in the concentration of 1 and no production of a predicted metabolite GDP during the assay. MS/MS also confirmed the absence of a possible pseudo-trisaccharide product. The results clearly show that 1 is neither a slow-reacting donor nor does it act as a suicide-type inhibitor toward Fuc-T V. ESI-MS/MRM is therefore a powerful tool for the kinetic characterization of enzyme inhibitors, providing complete disclosure of the mechanism of action of 1 as an inhibitor.


Subject(s)
Enzyme Inhibitors/chemistry , Guanosine/chemistry , Fucosyltransferases/antagonists & inhibitors , Fucosyltransferases/chemistry , Guanosine/analogs & derivatives , Guanosine Monophosphate/chemistry , Indicators and Reagents , Kinetics , Regression Analysis , Spectrometry, Mass, Electrospray Ionization
SELECTION OF CITATIONS
SEARCH DETAIL
...